Annual ROE
-56.80%
-12.23%-27.44%
December 31, 2023
Summary
- As of February 20, 2025, VRDN annual return on equity is -56.80%, with the most recent change of -12.23% (-27.44%) on December 31, 2023.
- During the last 3 years, VRDN annual ROE has risen by +106.27% (+65.17%).
- VRDN annual ROE is now -268.90% below its all-time high of 33.63%, reached on December 31, 2012.
Performance
VRDN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-50.51%
+2.44%+4.61%
September 30, 2024
Summary
- As of February 20, 2025, VRDN quarterly return on equity is -50.51%, with the most recent change of +2.44% (+4.61%) on September 30, 2024.
- Over the past year, VRDN quarterly ROE has increased by +11.25% (+18.22%).
- VRDN quarterly ROE is now -113.56% below its all-time high of 372.36%, reached on September 30, 2014.
Performance
VRDN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VRDN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | +18.2% |
| 3 y3 years | +65.2% | +18.2% |
| 5 y5 years | +22.0% | +18.2% |
VRDN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | at low | -1.1% | +24.1% |
| 5 y | 5-year | -27.4% | +65.2% | -1.1% | +81.3% |
| alltime | all time | -268.9% | +77.4% | -113.6% | +81.3% |
Viridian Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -50.51%(-4.6%) |
| Jun 2024 | - | -52.95%(-4.1%) |
| Mar 2024 | - | -55.23%(-17.0%) |
| Dec 2023 | -56.80%(+27.4%) | -66.52%(+7.7%) |
| Sep 2023 | - | -61.76%(+0.6%) |
| Jun 2023 | - | -61.37%(+4.2%) |
| Mar 2023 | - | -58.89%(+17.9%) |
| Dec 2022 | -44.57%(-13.6%) | -49.94%(-1.9%) |
| Sep 2022 | - | -50.92%(-17.0%) |
| Jun 2022 | - | -61.38%(+8.2%) |
| Mar 2022 | - | -56.72%(+2.5%) |
| Dec 2021 | -51.61%(-68.4%) | -55.36%(-56.8%) |
| Sep 2021 | - | -128.24%(-29.0%) |
| Jun 2021 | - | -180.66%(-11.9%) |
| Mar 2021 | - | -205.13%(-24.0%) |
| Dec 2020 | -163.07%(+30.7%) | -270.03%(+94.1%) |
| Sep 2020 | - | -139.14%(-6.4%) |
| Jun 2020 | - | -148.62%(+8.9%) |
| Mar 2020 | - | -136.43%(+7.3%) |
| Dec 2019 | -124.81% | -127.15%(+26.7%) |
| Sep 2019 | - | -100.35%(+28.0%) |
| Jun 2019 | - | -78.41%(+16.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -67.61%(+20.3%) |
| Dec 2018 | -72.79%(-47.6%) | -56.20%(+8.8%) |
| Sep 2018 | - | -51.64%(+4.6%) |
| Jun 2018 | - | -49.37%(-2.2%) |
| Mar 2018 | - | -50.50%(-36.6%) |
| Dec 2017 | -138.86%(-44.8%) | -79.62%(-17.8%) |
| Sep 2017 | - | -96.84%(-10.6%) |
| Jun 2017 | - | -108.37%(-13.9%) |
| Mar 2017 | - | -125.85%(-41.3%) |
| Dec 2016 | -251.37%(+82.0%) | -214.48%(+80.8%) |
| Sep 2016 | - | -118.62%(+1.5%) |
| Jun 2016 | - | -116.86%(+13.2%) |
| Mar 2016 | - | -103.22%(-3.2%) |
| Dec 2015 | -138.14%(+4.9%) | -106.61%(+1.0%) |
| Sep 2015 | - | -105.54%(+7.0%) |
| Jun 2015 | - | -98.65%(-26.1%) |
| Mar 2015 | - | -133.55%(-0.1%) |
| Dec 2014 | -131.70%(-1556.9%) | -133.68%(-135.9%) |
| Sep 2014 | - | 372.36%(+237.3%) |
| Jun 2014 | - | 110.41%(+427.8%) |
| Mar 2014 | - | 20.92%(+131.4%) |
| Dec 2013 | 9.04%(-73.1%) | 9.04% |
| Dec 2012 | 33.63% | - |
FAQ
- What is Viridian Therapeutics annual return on equity?
- What is the all time high annual ROE for Viridian Therapeutics?
- What is Viridian Therapeutics annual ROE year-on-year change?
- What is Viridian Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly ROE year-on-year change?
What is Viridian Therapeutics annual return on equity?
The current annual ROE of VRDN is -56.80%
What is the all time high annual ROE for Viridian Therapeutics?
Viridian Therapeutics all-time high annual return on equity is 33.63%
What is Viridian Therapeutics annual ROE year-on-year change?
Over the past year, VRDN annual return on equity has changed by -12.23% (-27.44%)
What is Viridian Therapeutics quarterly return on equity?
The current quarterly ROE of VRDN is -50.51%
What is the all time high quarterly ROE for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly return on equity is 372.36%
What is Viridian Therapeutics quarterly ROE year-on-year change?
Over the past year, VRDN quarterly return on equity has changed by +11.25% (+18.22%)